Resumen
Caspofungin inhibits the synthesis of 1,3-β-D-glucan, a key step in fungal cell wall biosynthesis. Here we report on its potent in vitro activity (MIC at which 90% of the isolates tested are inhibited = 1 μg per ml of RPMI medium) against 32 Candida albicans fluconazole-susceptible and -resistant clinical isolates irrespective of the underlying resistance mechanism (alterations in ERG11 and/or upregulation of MDR and CDR genes encoding efflux pumps) and provide further evidence that caspofungin is not a substrate for multidrug transporters.
| Idioma original | English (US) |
|---|---|
| Páginas (desde-hasta) | 2228-2230 |
| Número de páginas | 3 |
| Publicación | Journal of clinical microbiology |
| Volumen | 40 |
| N.º | 6 |
| DOI | |
| Estado | Published - 2002 |
ASJC Scopus subject areas
- Microbiology (medical)
Huella
Profundice en los temas de investigación de 'In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance'. En conjunto forman una huella única.Citar esto
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS